Teleflex declares quarterly dividend of $0.34 per share

WAYNE, Pa. - Teleflex Incorporated (NYSE:TFX), a global provider of medical technologies with a market capitalization of $5 billion, announced Thursday that its Board of Directors has declared a quarterly cash dividend of $0.34 per share of common stock. According to InvestingPro data, the company has maintained dividend payments for 49 consecutive years, demonstrating a strong commitment to shareholder returns.

The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 15, 2025, according to a press release statement from the company. The current dividend yield stands at 1.19%, while analysis from InvestingPro suggests the stock is trading below its Fair Value.

Teleflex offers a diverse portfolio of solutions across multiple therapy areas including anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology.

The company’s product brands include Arrow, Barrigel, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift, and Weck.

Teleflex describes itself as focused on improving the health and quality of people’s lives through its medical technology offerings.

In other recent news, Teleflex Incorporated reported its Q1 2025 earnings, which showed a slight miss on both earnings per share (EPS) and revenue forecasts. The company posted an EPS of $2.91, falling short of the projected $2.95, and reported revenue of $700.7 million, which was below the anticipated $705.99 million. This earnings report also highlighted a 5% year-over-year decline in revenue. Additionally, Teleflex completed the acquisition of BIOTRONIK’s Vascular Intervention business for €760 million, enhancing its interventional access offerings and establishing a presence in the peripheral intervention market. Following this acquisition, Needham maintained a Hold rating on Teleflex stock, reflecting an updated financial model to account for the deal’s impact. Meanwhile, RBC Capital lowered its price target for Teleflex to $130 from $145, maintaining a Sector Perform rating. RBC cited investor hesitation due to previous guidance reductions and the company’s business separation plan, which is not expected until mid-2026. These recent developments provide a comprehensive look at the company’s current financial and strategic position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.